Gregory S. Bisacchi

Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus

Steven Innaimo, Maria Seifer, Gregory S. Bisacchi et al. · Antimicrobial Agents and Chemotherapy · 1997 · 273 citations · Full text

Hbv Replication, Viral Hepatitis, Mitochondrial Dna Content +14

A New-Class Antibacterial—Almost. Lessons in Drug Discovery and Development: A Critical Analysis of More than 50 Years of Effort toward ATPase Inhibitors of DNA Gyrase and Topoisomerase IV

Gregory S. Bisacchi, John I. Manchester · ACS Infectious Diseases · 2014 · 176 citations

Antibiotic Adjuvant, Antimicrobial Chemotherapy, Drug Resistance +19

BMS-200475, a novel carbocyclic 2′-deoxyguanosine analog with potent and selective anti-hepatitis B virus activity in vitro

Gregory S. Bisacchi, Sam Chao, C. Bachard et al. · Bioorganic & Medicinal Chemistry Letters · 1997 · 141 citations

Viral Hepatitis, Drug Discovery, Medicine +8

Structures, functions and adaptations of the human LINE-1 ORF2 protein

Eric T. Baldwin, Trevor van Eeuwen, David Hoyos et al. · Nature · 2023 · 107 citations · Full text

Metabolic Studies on BMS-200475, a New Antiviral Compound Active against Hepatitis B Virus

Gregory Yamanaka, T. P. Wilson, Steven Innaimo et al. · Antimicrobial Agents and Chemotherapy · 1999 · 106 citations · Full text

Antiviral Drug, Hepatitis B Virus, Viral Hepatitis +18